DRUG UTILIZATION STUDY FOR AZILSARTAN MEDOXOMIL IN GERMANYJOURNAL OF HYPERTENSIONIF4.12018-06-010PREAI
EFFICACY AND SAFETY OF THE NOVEL ANGIOTENSIN RECEPTOR BLOCKER, AZILSARTAN-MEDOXOMIL, IN KOREAN PATIENTS WITH ESSENTIAL HYPERTENSIONJOURNAL OF HYPERTENSIONIF4.12016-09-011PREAI
ACHIEVEMENT OF BLOOD PRESSURE TARGETS AND SAFETY OF AZILSARTAN MEDOXOMIL/CHLORTHALIDONE FIXED DOSE COMBINATION VERSUS AZILSARTAN MEDOXOMIL IN HYPERTENSIVE PATIENTS UNCONTROLLED ON MONOTHERAPYJOURNAL OF HYPERTENSIONIF4.12015-06-010PREAI
Cardiovascular safety of the dipetidyl peptidase-4 inhibitor alogliptin in type 2 diabetes mellitusDIABETES OBESITY & METABOLISMIF5.72013-04-04106PRE
In contrast to HIV, KIR3DS1 does not influence outcome in HTLV-1 retroviral infectionHUMAN IMMUNOLOGYIF2.22012-08-018OAAI
Changes of gastric histology in patients with erosive oesophagitis receiving long-term lansoprazole maintenance therapyALIMENTARY PHARMACOLOGY & THERAPEUTICSIF6.72010-06-0311PREAI
Common genetic variants and risk for non-Hodgkin lymphoma and adult T-cell lymphoma/leukemia in JamaicaINTERNATIONAL JOURNAL OF CANCERIF4.72009-07-1413PREAI
The clinical safety of long-term lansoprazole for the maintenance of healed erosive oesophagitisALIMENTARY PHARMACOLOGY & THERAPEUTICSIF6.72009-05-2118OAAI
Population differences in immune marker profiles associated with human T-lymphotropic virus type I infection in Japan and JamaicaINTERNATIONAL JOURNAL OF CANCERIF4.72008-11-0620OAAI
Hematologic and biochemical changes associated with human T lymphotropic virus type 1 infection in Jamaica: A report from the population-based blood donors studyCLINICAL INFECTIOUS DISEASESIF7.32007-10-155PREAI
Comparative mortality for 621 second cancers in 29356 testicular cancer survivors and 12420 matched first cancersJNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTEIF7.22007-08-0832OAAI
Risk of human T-lymphotropic virus type I-associated diseases in Jamaica with common HLA typesINTERNATIONAL JOURNAL OF CANCERIF4.72007-04-1619OAAI
Haplotypes of IL6 and IL10 and susceptibility to human T lymphotropic virus type I infection among childrenJOURNAL OF INFECTIOUS DISEASESIF4.52006-12-013OAAI
Natural history of viral markers in children infected with human T lymphotropic virus type I in JamaicaJOURNAL OF INFECTIOUS DISEASESIF4.52006-09-0116PREAI
Human T lymphotropic virus types I and II Western blot seroindeterminate status and its association with exposure to prototype HTLV-IJOURNAL OF INFECTIOUS DISEASESIF4.52006-02-0125PREAI
Human leukocyte antigen concordance and the transmission risk via breast-feeding of human T cell lymphotropic virus type IJOURNAL OF INFECTIOUS DISEASESIF4.52006-01-1553PREAI
Cancer survivorship - Genetic susceptibility and second primary cancers: Research strategies and recommendations癌症生存-遗传易感性和第二原发癌: 研究策略和建议JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTEIF7.22006-01-04264PREAI
Hepatitis C virus load and survival among injection drug users in the United StatesHEPATOLOGYIF15.82005-12-0138PREAI
Comments on the brief report Provirus load in breast milk and risk of mother-to-child transmission of human T lymphotropic virus type I - ReplyJOURNAL OF INFECTIOUS DISEASESIF4.52005-05-153OAAI
Discrete serum protein signatures discriminate between human retrovirus-associated hematologic and neurologic diseaseLEUKEMIAIF13.42005-05-1233PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向